Vinge has advised Attendo, the largest care company in the Nordic region, in connection with the conclusion of an agreement to acquire Team Olivia's Swedish care operations (excluding personal assistance). Attendo thereby strengthens its position within care for people with disabilities, individual and family care as well as home care in Sweden.

The acquisition means that approximately 120 care operations with about 3,200 customers and close to 3,000 employees will become part of the Attendo Group. Team Olivia conducts highly specialised care for people with complex care needs in disabled care and induvial and family care, which complements Attendo's existing operations in these areas . The transaction is expected to provide clear economies of scale, entailing increased resources for quality development, digitalisation and improvement of working methods in care-related work. The acquired business has annual sales of approximately SEK 1,350 million with a lease-adjusted operating profit of approximately SEK 130 million.

The purchase price amounts to SEK 950 million on a cash and debt-free basis.

Vinge's team mainly constisted of Jonas Bergström, Joacim Rydergård, Carl Sander, Isabelle Wållgren, Gustav Wahlberg and Sara Passandideh (M&A), Mathilda Persson and Elis Allmark (IT), Christoffer Nordin (Permits), Frida Ställborn and Madelene Andersson (Real Estate), Simon Söderholm and Olivia Onwuta (Employment), Nicklas Thorgenzon (GDPR), Karl-Gustaw Tobola och Sofia Haggren (Financing), Sofia Bergenstråhle (IP), Julia Löfqvist and Maja Höglund (Compliance), Sebastian Öhrndahl, Daniel Wendelson, Lovisa Lewin, Dagne Sabockis and Hilda Ivarsson (Regulatory), Kristoffer Sällfors (Public Procurement) and also Emy Rydén and Christoffer Widström (Transaction Support Coordinators).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025